Skip to main content
OliX Pharmaceuticals, Inc. logo

OliX Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · 226950 ISIN · KR7226950004 KO Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2024-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 226950

About OliX Pharmaceuticals, Inc.

https://olixpharma.com

OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Olix Inc. (올릭스 주식회사) covering the fiscal years 2022 and 2023. It includes the independent auditor's opinion, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and notes to the financial statements. It is a comprehensive financial document, not an announcement or a summary, and fits the definition of an Audit Report/Information (AR). FY 2023
2024-03-18 Korean
[기재정정]사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) from a Korean company, Olix Inc. It contains detailed financial data, including capital changes, shareholding status, business descriptions, and management information for the fiscal year 2023. In the Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K, serving as the comprehensive annual report covering company activity and financial performance. It is not an announcement of a report, but the report itself. FY 2023
2024-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company 'OliX' (올릭스) on March 14, 2024. It contains the auditor's opinion (적정 - Unqualified), financial statements (consolidated and separate), and key financial metrics such as assets, liabilities, and profit/loss. This document is a standard regulatory filing in Korea (DART system) that provides the results of the annual audit, which falls under the 'Audit Report / Information' category. FY 2023
2024-03-14 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Olix Inc. It contains the agenda for the 14th Annual General Meeting, including items such as financial statement approval, director appointments, and remuneration limits. While it contains management information and financial data, the primary purpose of this specific filing is to formally notify shareholders of the upcoming meeting and provide the necessary proxy materials and agenda items. In the context of regulatory filings, this is classified as a Proxy Solicitation & Information Statement.
2024-03-13 Korean
기타시장안내 (연구개발 우수기업 매출액 특례적용 관련)
Regulatory Filings Classification · 100% confidence The document is a short announcement from the KOSDAQ market regarding a specific regulatory status (R&D excellence revenue exemption) for the company Olix. It does not contain full financial statements or a comprehensive report, but rather serves as a formal regulatory notification to the market. Given it is a specific regulatory announcement that does not fit into categories like dividends, M&A, or share issues, it falls under the general regulatory filing category.
2024-02-29 Korean
주주총회소집결의 (정기주주총회)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company Olix. It details the date, location, and agenda items for the upcoming Annual General Meeting, including the election of directors and auditors. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items for voting purposes.
2024-02-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.